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Abstract 
 
Renal malignancies are common in children. While the majority of malignant renal masses 
are secondary to Wilms tumor, it can be challenging to distinguish from more aggressive 
renal masses. For suspicious renal lesions, it is crucial to ensure prompt diagnosis in order 
to select the appropriate surgical procedure and treatment. This review article will discuss 
the common differential diagnosis that can be encountered when evaluating a suspicious 
renal mass in the pediatric population. This includes clear cell sarcoma of the kidney, 
malignant rhabdoid tumor, renal medullary carcinoma and lymphoma. Copyright: The Authors. 
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Introduction 
 
Renal malignancies are common in 
children.  Favorable histology Wilms tumor 
(FHWT) is the most common subtype of 
Wilms and, fortunately, also has the best 
prognosis with overall survival greater than 
90%. Despite advances in treatment 
achieved with Wilms tumor, 30% of 
pediatric renal tumors still have overall 
survival less than 70%.  This emphasizes 
the need for development of multimodal 
biological treatment regimens and further 
understanding of prognostic biomarkers 
(1). Improved detection methods for 
different pediatric renal malignancies and 
subsequent specific clinical trials would be 
beneficial.  It is paramount for clinicians to 
correctly identify the lesion and select the 
optimal treatment. 
 
Wilms Tumor 
 
An impressive 87% of pediatric renal 
masses are Wilms tumor (nephroblastoma), 
which makes up 7% of childhood 
malignancies and is the fourth most 
common childhood cancer overall (2-4). 
Each year in the United States about 500 
children are diagnosed with Wilms tumor 
with 80% of patients presenting before 5 
years of age (5).   It arises from persistent 
metanephric blastema, and is subdivided 
into FHWT, anaplastic Wilms tumor 
(AHWT), and blastemal-type Wilms.  
Children with Beckwith-Wiedemann 
syndrome, WAGR syndrome and Denys-
Drash syndrome, have increased risk of 
Wilms tumor and may be screened with 
ultrasound up until about age 6 years. 
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Figure 1. A, Large left renal mass in a 4-year old female with central areas of necrosis (arrow). 
Diagnosis was Wilms tumor on surgical pathology; B, Three-year old female with a left renal mass 
(Wilms tumor) with associated retroperitoneal lymphadenopathy (long arrow). There is also 
extracapsular extension of the tumor (short arrow). C, CT of the chest showed multiple metastatic 
pulmonary nodules; D, Five-year old female with bilateral Wilms tumor. Large left renal mass and a 
smaller right renal mass (arrow). Bilateral partial nephrectomies were performed; E, 
Nephroblastomatosis. Eighteen-month old female with an enlarged abdomen. Axial post contrast MRI 
shows bilateral nephromegaly containing multiple lobulated parenchymal masses with streaky 
enhancement; F, Six-year old female with a right renal mass (arrow). This was a renal cell carcinoma 
on surgical pathology after nephrectomy. 
 
 
While it can be discovered during 
coincidental trauma in up to 10% of cases 
(6), Wilms tumor commonly presents as a 
palpable abdominal mass (palpated by 
parents or on physical exam by 
physicians); it can be associated with 
hypertension (in up to 25% of cases, 
caused by renin produced by tumor cells), 
and hematuria (7).  The mass may contain 
hemorrhage, calcification, fat, or necrosis 
and may invade the renal vein or inferior 
vena cava (IVC).  On imaging, the classic 
appearance is a heterogeneous solid renal 
mass with a “claw sign” indicating its origin 
from the renal parenchyma (Figure 1A).  
Tumor extension into the renal vein and 
IVC is seen in 5-10%. Wilms tumor most 
frequently metastasizes to the lungs 
(Figure 1B,C) (8). Wilms Tumor is bilateral 
in 4-13% of cases (Figure 1D).   A cystic 
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Figure 2. A, Ten-year old African-American male with sickle-cell trait. Coronal CT scan shows a 
centrally located and infiltrating left renal mass. Nephrectomy was performed and surgical pathology 
came back as renal medullary carcinoma. B, Large right renal mass in a 7-month old male. 
Nephrectomy was performed and the surgical pathology revealed a rhabdoid tumor. C, Two -year old 
male with a large left renal mass indistinguishable from a Wilms tumor. The mass was a clear cell 
sarcoma on surgical pathology. D, Four-year old female with history of abdominal enlargement. The 
kidneys are enlarged and show multiple hypodensities. There are also enlarged retroperitoneal lymph 
nodes (arrow); E, Follow-up CT 5 months later after chemotherapy showing normal kidneys and 
resolution of the retoperitoneal lymphadenopathy. 
 
 
 
variant of Wilms tumor may mimic benign 
multilocular cystic nephroma. 
 
The National Wilms Tumor Study (NWTS) 
and Societe Internationale D’Oncologie 
Pediatrique (SIOP) have made large 
contributions to the modern multimodal 
treatment, which consists of surgical 
excision, radiotherapy, and chemotherapy 
(adjuvant and/or neoadjuvant). Minimally 
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invasive laparoscopic surgery has also 
increased in popularity.  These oncologic 
treatments achieve a remarkable long-term 
overall survival rate of 90%, however, 25% 
of survivors have serious chronic therapy-
related health conditions up to 25 years 
later (9). Anaplastic, bilateral, or relapsed 
disease has a lower survival rate (10). 
 
Nephroblastomatosis 
 
Nephroblastomatosis is a rare pre-
neoplastic precursor to Wilms tumor.  It is 
defined as multiple nephrogenic rests or 
abnormal foci of persistent metanephric 
blastema beyond 36 weeks of gestation.  
Normally nephrogenesis completes at 36 
weeks gestation with metanephric blastema 
forming nephrons and eventually the renal 
cortex.  Nephrogenic rests are present in 
1% of infants at autopsy, and malignant 
transformation occurs in less than 1% of 
nephrogenic rests.  They can be perilobar 
(at the periphery of the renal lobe) or 
intralobar (within the renal lobe).  More 
than 30% of Wilms tumors arise from 
nephrogenic rests, which are found in 
nearly all patients with bilateral Wilms. 
 
Screening is recommended at 3-month 
intervals for nephroblastomatosis to detect 
malignant transformation.  Ultrasound 
may reduce both cost and use of 
anesthesia for sedation and can detect 
masses, however MRI is the method of 
choice for follow-up (11). On imaging, 
nephroblastomatosis appear as discrete, 
homogeneous, non-enhancing renal 
masses (Figure 1E).  Any rapid growth, 
inhomogeneity, or heterogeneous 
enhancement is considered worrisome for 
development of Wilms. 
 
Renal Cell Carcinoma 
 
Renal cell carcinoma (RCC) makes up 1% 
of all pediatric renal malignancies.  In the 
pediatric setting it is typically seen in Von 
Hippel-Lindau disease, which is associated 
with retinal and central nervous system 
hemangioblastomas, pheochromocytomas, 
and pancreatic neuroendocrine tumors.  
On imaging RCC is indistinguishable from 
Wilms tumor (Figure 1F), though it tends 
to be smaller at presentation and is 
calcified in 25% (12).  The 5-year survival 
rate is less than 70% (13). 
Renal Medullary Carcinoma 
 
Renal medullary carcinoma is an 
aggressive tumor almost exclusively seen in 
young (age11-39years), African-American 
patients with sickle cell hemoglobinopathy 
(14). It usually presents at an advanced 
stage and typically poorly responds to 
treatment. It is an epithelial tumor arising 
from the collecting duct epithelium. While 
there is no specific imaging appearance, it 
is located deep within the renal pelvis and 
sinus (Figure 2A) in contradistinction to 
Wilms and RCC which are usually located 
in the renal cortex. 
Immunohistochemically, renal medullary 
carcinoma stains positive for CAM 5.5 and 
epithelial membrane antigen, negative for 
cytokeratin 34EE12, and variable for 
cytokeratins 7, 20, and carcinoembrionic 
antigen (15). Surgery, chemotherapy, and 
radiation have been used, however the 
average reported survival continues to be 
very poor at 15 weeks from diagnosis (16).  
Awareness and early detection may help 
increase survival and thus cytologic 
evaluation of urine and computed 
tomography (CT) imaging may be 
appropriate for patients with sickle cell 
trait presenting with persistent renal 
symptoms of hematuria, flank pain, and 
weight loss. 
 
Malignant Rhabdoid Tumor (MRT) 
 
MRT is a rare, aggressive malignancy that 
most commonly originates in the kidney 
(Figure 2B) but can also occur in the 
central nervous system and other 
extrarenal sites.  It is commonly diagnosed 
between 0-3 years of age.  It is also 
associated with extensive metastasis at the 
time of diagnosis and can have a 
synchronous brain tumor. A key to the 
diagnosis is negativity of 
immunohistochemistry for SWI/SNF-
related, matrix-associated, actin-dependent 
regulator of chromatin, sub-family B, 
member 1 INI1 (SMARCB1) (17). There is 
no standard treatment for MRT and 
prognosis is very poor with published 
overall survivals of 15-36%, however more 
recent treatment regimens including 
surgery, radiotherapy, high dose 
chemotherapy and autologous stem cell 
rescue (HDCT/ASCR) may improve survival 
with one center reporting overall survival of 
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66.7% with a median follow up of almost 2 
years (18). 
 
Clear cell sarcoma of the kidney (CCSK) 
 
CCSK is the second most common renal 
tumor in children with a mean age of 
diagnosis overlapping with Wilms tumor.  
Clinical presentation includes abdominal 
pain, hypertension, and hematuria.  CCSK 
is aggressive with a unique propensity to 
metastasize to bone and brain, as well as 
lung and abdomen (19).  It is virtually 
indistinguishable from Wilms tumor on 
imaging (Figure 2C).  Treatment consists of 
radical nephrectomy, chemotherapy, and 
radiotherapy.  While prognosis traditionally 
has been poor, newer treatment regimens 
show relapse-free and cancer-specific 
survival rate of 100% for revised stage 1 
CCSK (20) and overall survival rate for 
patients with CCSK of 83% (21). 
 
Lymphoma 
 
Primary lymphoma of the kidney is 
extremely rare since the kidney has no 
lymphatic system. Disease involvement is 
mainly due to hematogenous or direct 
spread from adjacent lymph nodes.  The 
kidneys are involved in 12% of children 
with non-Hodgkin’s lymphoma.  On 
imaging, lymphoma may have a variety of 
appearances that include multiple bilateral 
low-attenuation masses (Figure 2D, E), 
areas of geographic wedge shaped low 
attenuation, unilateral solitary low-
attenuation mass, unilateral large 
conglomerate masses, or unilateral 
nephromegaly seen on CT (22).  Lymphoma 
may mimic nephroblastomatosis, however, 
lymphoma occurs typically in older 
children and is associated with 
lymphadenopathy elsewhere in the body. 
 
Treatment is mainly with chemotherapy; 
however careful nephrological monitoring is 
necessary during treatment since excretion 
of tumor metabolites may result in renal 
obstructive or uric acid nephropathy (23). 
 
Conclusion 
 
Although Wilms tumor is the most common 
pediatric renal malignancy, it is often 
indistinguishable from other rare but more 
aggressive masses like RCC and MRT. 
Imaging and histologic characterization are 
crucial to avoid delay in management.  New 
treatment regimens continue to improve 
survival rates, however further research 
and advancement in knowledge is still 
necessary to improve outcomes and 
decrease treatment-related long-term 
complications.  
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